Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

Current Opinion in Lipidology

Volumn 12, Issue 4, 2001, Pages 377-382

  Barter, Philip J ^a,b   Rye, Kerry Anne ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DISEASE; ATHEROGENESIS; CHOLESTEROL METABOLISM; HUMAN; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; RABBIT; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; OLIGONUCLEOTIDES, ANTISENSE; POLYMORPHISM, GENETIC;

EID: 0034925152     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200108000-00002     Document Type: Review

References (43)

1. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
2. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
3. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
4. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
5. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice
6. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
7. High density lipoproteins and coronary heart disease
8. Intracellular cholesterol transport
9. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
10. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
11. CETP and atherosclerosis
12. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
13. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
14. Pros and cons of inhibiting cholesteryl ester transfer protein
15. Transfers and exchanges of esterified cholesterol between plasma lipoproteins
16. Evidence that CETP-mediated reductions in reconstituted high density lipoprotein size involve particle fusion
17. Remodelling of high density lipoproteins by plasma factors
18. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities
19. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins
20. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
21. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits
22. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis
23. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
24. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
25. Increased atherosclerosis in apoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
26. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
27. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
28. Cholesteryl ester transfer protein gene: Two common mutations and their effect on plasma high-density lipoprotein cholesterol content
29. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan
30. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
31. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
32. A low prevalence of coronary heart disease among subjects with increased high density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency
33. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
34. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population
35. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoproteins subclasses and coronary heart disease risk
36. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients
37. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
38. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease
39. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
40. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene - Environment interaction
41. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit
42. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase
43. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis